VeriMommagnolia kobus bark extract은 임신 중 안전한가요?
No EU ban/restriction or harmonised CMR classification found for Magnolia kobus bark extract/CAS 223749-80-2 (CosIng entry exists), but animal studies on major Magnolia bark constituents (honokiol, magnolol) report embryo–fetal effects or placental/uterine effects in rodents, so reproductive hazard is suspected. Example studies: an embryo–fetal toxicity study of honokiol in pregnant rats and animal data showing magnolol alters placental morphology and can inhibit uterine contraction. CosIng/industry listings and EWG do not override these animal findings. Sources: PubMed studies and WHO monograph noted below.
Pregnancy-safe products containing magnolia kobus bark extract
임신 중 magnolia kobus bark extract 대체 안전 성분 | VeriMom
Related ingredients
Frequently asked questions
- magnolia kobus bark extract은 임신 중 안전한가요?
- No EU ban/restriction or harmonised CMR classification found for Magnolia kobus bark extract/CAS 223749-80-2 (CosIng entry exists), but animal studies on major Magnolia bark constituents (honokiol, magnolol) report embryo–fetal effects or placental/uterine effects in rodents, so reproductive hazard is suspected. Example studies: an embryo–fetal toxicity study of honokiol in pregnant rats and animal data showing magnolol alters placental morphology and can inhibit uterine contraction. CosIng/industry listings and EWG do not override these animal findings. Sources: PubMed studies and WHO monograph noted below.
- magnolia kobus bark extract은 모유 수유 중 안전한가요?
- No harmonised classification or EU Annex II/III listing found; however the same animal data and mechanistic evidence (placental/uterine activity and systemic activity of isolated constituents) justify a suspected hazard and demonstrated mechanism. Transfer into breastmilk is not directly studied for the extract, but systemic bioactivity of honokiol/magnolol supports cautious classification as suspected (h=2). Exposure from topical cosmetic use is likely low but measurable.
- magnolia kobus bark extract은 아기 피부에 안전한가요?
- Baby skin exposure: do not increase h or m without infant-specific evidence, but exposure score is increased because infant skin has higher absorption. The ingredient contains small lipophilic active constituents (honokiol/magnolol) with demonstrated systemic activity in animals; therefore exposure for 0–3 yr olds is scored higher (adult e=1 → baby e=2). No infant-specific safety studies located.
- VeriMom은 magnolia kobus bark extract을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 magnolia kobus bark extract을 40/100 (중간 위험)로 평가합니다.
- 임신 중 magnolia kobus bark extract 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.